Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2013
12/11/2013EP2670745A1 Spiro aminic compounds with nk1 antagonist activity
12/11/2013EP2670744A1 Pyrrole derivatives used as modulators of alpha7 nachr
12/11/2013EP2670722A1 Chiral 1-(4-methylphenylmethyl)-5-oxo-{n-[(3-t-butoxycarbonyl-aminomethyl)]-piperidin-1-yl}-pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and adhesion
12/11/2013EP2670401A1 Methods of using alk inhibitors
12/11/2013CN1956952B Histamine H3 receptor agents, preparation and therapeutic uses
12/11/2013CN103443094A Pyrazole derivative
12/11/2013CN103443093A Novel compounds as histamine H3 receptor ligands
12/11/2013CN103443092A Pyrrole derivatives used as modulators of alpha7 nachr
12/11/2013CN103443080A Sulfonamide compounds having TRPM8 antagonistic activity
12/11/2013CN103443079A Fluoro-pyridinone derivatives useful as antibacterial agents
12/11/2013CN103443078A Cyanoenamines and their use as fungicides
12/11/2013CN103443076A Indol-2-one derivatives disubstituted in the 3-osition, preparation thereof and therapeutic use thereof
12/11/2013CN103443074A Heterocyclic amine derivatives
12/11/2013CN103442712A Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/11/2013CN103442569A Ectoparasiticidal active substance combinations
12/11/2013CN103436251A Ratio meter type two-photon cadmium ion fluorescent probe and synthetic method thereof
12/11/2013CN103435611A Multi-target point alpha-pyridoin compounds and preparation method and application thereof
12/11/2013CN103435606A CDK2 and CSK3beta dual inhibitor and application thereof
12/11/2013CN103435596A Tetrazole substituted anthranilic acid amides as pesticides
12/11/2013CN103435595A Acetylenic heteroaryl compounds
12/11/2013CN103435594A 2-amino-quinazolines PLK1 (Polo-like kinase1) inhibitor and application thereof
12/11/2013CN103435562A 6-substituted benzodiazepine-2,4-diketone compound and application thereof
12/11/2013CN103435554A 2-phenylaminobenzimidazole compound and application thereof
12/11/2013CN103435551A 2-substituted benzimidazole compound preparation method
12/11/2013CN103435544A 喹诺酮化合物 Quinolone compounds
12/11/2013CN102633713B Dabigatran etexilate intermediate, preparation method for same and method for preparing dabigatran etexilate
12/11/2013CN102627628B Chlorantraniliprole antigen, its preparation method and application
12/11/2013CN102584796B Bis-Schiff bases synthesized by condensing indole-3-carboxaldehyde and pyridine diamine and preparation method thereof
12/11/2013CN102471316B Insecticidal Compounds
12/11/2013CN102333772B Anti-viral compounds
12/11/2013CN102153538B Benzocyclodirivative
12/11/2013CN102066353B Disubstituted phthalazine Hedgehog pathway antagonists
12/11/2013CN102040591B 7-phenyl quinolone compounds
12/11/2013CN101888999B Pyridylmethyl-sulfonamide compounds
12/11/2013CN101516844B 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system
12/11/2013CN101405281B Inhibitors of the interaction between MDM2 and P53
12/10/2013US8604217 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
12/10/2013US8604210 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
12/10/2013US8604199 Insecticidal pyridine compounds
12/10/2013US8604062 Process for the preparation of isoxazolyl-methoxy nicotinic acids
12/10/2013US8604046 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
12/10/2013US8604042 Bi-aryl meta-pyrimidine inhibitors of kinases
12/10/2013US8604040 Pyridinylcarboxylic acid derivatives as fungicides
12/10/2013US8604037 Therapeutic agents useful for treating pain
12/10/2013US8604036 Pyridazinone derivatives
12/10/2013US8604032 Chemical compounds, compositions and methods for kinase modulation
12/10/2013US8604022 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
12/10/2013US8604020 Fluoroquinolone carboxylic acid molecular crystals
12/10/2013US8603646 Pyrrole compound and organic photoelectric device including the same
12/10/2013CA2810655C Modulators of atp-binding cassette transporters
12/10/2013CA2656825C Method of treatment and agents useful for same
12/10/2013CA2608957C Pyrrolidine derivative or salt thereof
12/10/2013CA2608087C Methods for synthesizing heterocyclic compounds
12/10/2013CA2605272C Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
12/10/2013CA2599511C 2-(4-oxo-4h-quinazolin-3-yl) acetamides and their use as vasopressin v3 antagonists
12/10/2013CA2582911C Chemokine-binding heterocyclic compound salts, and methods of use thereof
12/10/2013CA2552317C Hcv ns-3 serine protease inhibitors
12/05/2013WO2013181251A1 Crizotinib hydrochloride salt in crystalline
12/05/2013WO2013180949A1 Substituted quinoline compounds and methods of use
12/05/2013WO2013180656A1 ICMT Inhibitors
12/05/2013WO2013180456A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
12/05/2013WO2013180128A1 4-[4-(5-membered aromatic heterocyclic carbonyl ureide)phenyloxy]quinoline derivative
12/05/2013WO2013180066A1 Pyridine derivative having inhibitory effect on tlr
12/05/2013WO2013179194A1 Process for the preparation of crystalline dexlansoprazole
12/05/2013WO2013179024A1 Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
12/05/2013WO2013178816A1 Heterocycles capable of modulating t-cell responses, and methods of using same
12/05/2013WO2013178591A1 Aminoquinazoline and pyridopyrimidine derivatives
12/05/2013WO2013178570A1 Substituted pyrrolidine-2-carboxamides
12/05/2013WO2013178075A1 N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and antitumor application thereof
12/05/2013WO2013177985A1 Nitrogenous heterocyclic imide derivative and preparation method and use thereof
12/05/2013WO2013153479A3 Indole and indazole compounds that activate ampk
12/05/2013WO2013129692A3 Nitrogen-containing heterocyclic derivative having 2-imino group and pest control agent including the same
12/05/2013WO2013124385A3 Solid forms of dabigatran etexilate mesylate and processes for their preparation
12/05/2013US20130324728 Process for the preparation of an orexin receptor antagonist
12/05/2013US20130324726 Method for producing imatinib base
12/05/2013US20130324725 Aminopyrimidines useful as kinase inhibitors
12/05/2013US20130324724 Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds
12/05/2013US20130324576 Therapeutic compounds
12/05/2013US20130324568 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
12/05/2013US20130324566 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof
12/05/2013US20130324560 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
12/05/2013US20130324556 Protease Activated Receptor 2 (PAR2) Antagonists
12/05/2013US20130324553 Microbiocidal pyrazole derivatives
12/05/2013US20130324552 Chemokine cxcr4 receptor modulators and used related thereto
12/05/2013US20130324550 1-(2-phenoxymethylheteroaryl) piperidine and piperazine compounds
12/05/2013US20130324546 Selective fak inhibitors
12/05/2013US20130324536 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
12/05/2013US20130324532 Fak inhibitors
12/05/2013US20130324531 Substituted pyrrolidine-2-carboxamides
12/05/2013US20130324530 3-(aminoaryl)-pyridine compounds
12/05/2013US20130324529 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
12/05/2013US20130324524 2,4-pyrimidinediamine compounds and their uses
12/05/2013US20130324523 Tau imaging probe
12/05/2013US20130324522 Insect odorant receptor antagonists
12/05/2013US20130324521 Implant for treating or preventing an aneurysm
12/05/2013US20130324519 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
12/05/2013US20130324518 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/05/2013US20130324517 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
12/05/2013US20130324507 Novel (aza)Benzhydryl Ether Derivatives, Their Process of Preparation and Their Use as H4-Receptor Ligands for Therapeutical Applications
12/05/2013US20130324501 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 1080